Proton pump inhibitor effect

From Libre Pathology

Revision as of 17:45, 10 January 2014 by Michael (talk | contribs) (create)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Proton pump inhibitor effect, abbreviated PPI effect, is a change seen in the parietal cells of the stomach due to a drug in the proton pump inhibitor class.

General

Due to intake of a proton pump inhibitor (PPI).
- Used to treat gastroesophageal reflux disease.

Microscopic

Features:^[1]

Parietal cell enlargement - key feature.

Sign out

Usually not reported.

See also

Stomach.

References

↑ Driman, DK.; Wright, C.; Tougas, G.; Riddell, RH. (Oct 1996). "Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.". Dig Dis Sci 41 (10): 2039-47. PMID 8888719.

Retrieved from "https://librepathology.org/w/index.php?title=Proton_pump_inhibitor_effect&oldid=27692"

Stomach